RX+
Live / Applied — Fourth extension granted (statement of use) (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 28 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97816484
- Mark type
- Design + words
- Filed
- 28 Feb 2023
- Published for opposition
- 24 Oct 2023
- Attorney of record
- Christopher Bolinger
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct; Reagent paper for medical purposes
- Class 009 — Scientific and electric apparatus: Downloadable medical software for processing and displaying images on ultrasound medical imaging machines; downloadable computer software for controlling and managing patient medical information; downloadable medical software for processing and displaying affected part images on medical resonance imaging machines (MRIs); downloadable software for medical imaging equipment, namely, for interpreting the results of CT scanners; downloadable computer programs for use in the operation of medical ultrasound detectors; downloadable computer software for medical examination for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct and for conducting medical diagnostic testing
- Class 010 — Medical apparatus: Medical apparatus for detecting and treating for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct and diagnostic imaging
- Class 041 — Education and entertainment services: Instruction in the field of dosage management; entertainment services, namely, providing online computer games; providing therapeutic exercise instruction; sports club services, namely, physical fitness instruction
- Class 042 — Scientific and technological services: Providing temporary use of on-line non-downloadable computer programs for use in medical examination for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct; scientific research and development; medical research and development; providing scientific research information in the field of clinical trials
- Class 044 — Medical, beauty and agricultural services: Medical service; medical diagnostic testing services; surgery support services related to medical care for type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct
Owner
- Astellas Pharma Inc., Tokyo, JP
- Astellas Pharma Inc., Tokyo, JP
Prosecution history
- 27 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2026 — SOU EXTENSION 4 GRANTED
- 19 Dec 2025 — SOU EXTENSION 4 FILED
- 26 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Jan 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 19 Jan 2026 — NOTICE OF REVIVAL - E-MAILED
- 19 Jan 2026 — PETITION TO REVIVE-GRANTED
- 19 Jan 2026 — TEAS PETITION TO REVIVE RECEIVED
- 19 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jun 2025 — SOU EXTENSION 3 GRANTED
- 11 Jun 2025 — SOU EXTENSION 3 FILED
- 11 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Apr 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS